A long-awaited video game meant to be prescribed to kids with ADHD is finally being rolled out — though not in the way its maker, Akili Interactive Labs, had ever imagined.

On Wednesday, the Boston-based startup launched an enrollment website to make its game available for free for eligible children for up to three months during the pandemic period. The rollout comes in response to the Food and Drug Administration’s move last week to relax regulations on low-risk mental health devices. Akili’s game is still pending regulatory approval, and as such it won’t be prescribed by physicians or covered by insurers as part of the unusual launch.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy